Laura Eve Schanberg

Conference Arthritis Care Res (Hoboken) · August 25, 2026 OBJECTIVE: To assess the validity of the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in patients with chronic nonbacterial osteomyelitis (CNO). METHODS: Within the longitudinal patient registry of CNO, English-speak ... Full text Link to item Cite

PREDICTING CARDIOVASCULAR DISEASE RISK IN CHILDREN AND ADOLESCENTS WITH JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS USING THE APPLE (ATHEROSCLEROSIS PREVENTION IN PAEDIATRIC LUPUS ERYTHEMATOSUS) CLINICAL TRIAL COHORT

Conference RHEUMATOLOGY · April 2023 Link to item Cite

URINARY HER2: A NEW BIOMARKER OF PEDIATRIC LUPUS NEPHRITIS ACTIVITY

Conference PEDIATRIC NEPHROLOGY · November 2022 Link to item Cite

Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes.

Conference Arthritis Care Res (Hoboken) · December 2021 OBJECTIVE: Down syndrome-associated arthritis (DA) is underrecognized, and current therapies used for juvenile idiopathic arthritis (JIA) appear to be poorly tolerated and less effective in patients with DA. The objective of this study was to characterize ... Full text Link to item Cite

Global impressions of change for instrument validation: Adult problems in pediatric samples

Conference QUALITY OF LIFE RESEARCH · October 2021 Link to item Cite

Enhancing understanding of Patient-Reported Outcomes Measurement Information System® (PROMIS) pediatric measures of symptoms and functioning in relation to disease activity for youth with juvenile idiopathic arthritis and systemic lupus erythematosus

Conference QUALITY OF LIFE RESEARCH · October 2020 Link to item Cite

Responsiveness of PROMIS (R) Pediatric measures to changes in health-related quality of life among children and adolescents undergoing treatment for cancer

Conference QUALITY OF LIFE RESEARCH · October 1, 2019 Link to item Cite

Identifying clinically meaningful severity categories for symptom experience or functional impairment for PROMIS Pediatric measures of anxiety, mobility, and fatigue in Juvenile Idiopathic Arthritis

Conference QUALITY OF LIFE RESEARCH · October 1, 2018 Link to item Cite

Global Consensus Building and Prioritization of Major Challenges in Lupus Diagnosis, Care, Treatment and Research

Conference ARTHRITIS & RHEUMATOLOGY · September 1, 2018 Link to item Cite

The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA Study: Updated Report of Baseline Patient Characteristics and Treatment Choices

Conference ARTHRITIS & RHEUMATOLOGY · September 1, 2018 Link to item Cite

Patients with Childhood-Onset SLE (cSLE) and Hypertension Have Consistently Higher Serum Concentrations of C3 and C4 Than Those without Hypertension

Conference ARTHRITIS & RHEUMATOLOGY · September 1, 2018 Link to item Cite

Pro-Inflammatory High Density Lipoprotein Function Is Associated with Accelerated Carotid Intimal Medial Thickness Progression in Childhood-Onset SLE

Conference ARTHRITIS & RHEUMATOLOGY · September 1, 2018 Link to item Cite

Hydroxychloroquine Level Decreases throughout Pregnancy: Implications for Maternal and Neonatal Outcomes

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2017 Link to item Cite

The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA Study: Interim Report of Baseline Patient Characteristics and Treatment Choices

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2017 Link to item Cite

Underutilization of Social Workers for Mental Health Care of Adolescents in Pediatric Rheumatology: A Mixed Methods Study

Conference ARTHRITIS & RHEUMATOLOGY · April 1, 2017 Link to item Cite

Corticosteroid Regimen Use in the Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis

Conference ARTHRITIS & RHEUMATOLOGY · April 1, 2017 Link to item Cite

Methotrexate use and route of administration in JIA: Results from the Childhood Arthritis & Rheumatology Research Alliance Registry

Conference ARTHRITIS & RHEUMATOLOGY · April 1, 2017 Link to item Cite

Baseline characteristics of the first 123 patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA comparative effectiveness study

Conference ARTHRITIS & RHEUMATOLOGY · April 1, 2017 Link to item Cite

Associations Between 25-Hydroxyvitamin D, Parathyroid Hormone, and Cathelicidin Concentrations with Inflammation and Cardiovascular Risk in Subjects with Pediatric Systemic Lupus Erythematosus

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2016 Link to item Cite

A Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2016 Link to item Cite

Patterns of Medication Use in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis & Rheumatology Research Alliance Registry

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2016 Link to item Cite

Multicenter Prospective Study on the Role of Urinary HER2 As a Lupus Nephritis Biomarker

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2016 Link to item Cite

A5.20 Low vitamin D status is associated with avascular necrosis: an atherosclerosis prevention in paediatric lupus erythematosus substudy

Conference Annals of the Rheumatic Diseases · March 2015 Full text Cite

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.

Conference Arthritis Rheumatol · September 2014 OBJECTIVE: To assess the efficacy and safety of rilonacept, an interleukin-1 inhibitor, in a randomized, double-blind, placebo-controlled trial. METHODS: An initial 4-week double-blind placebo phase was incorporated into a 24-week randomized multicenter de ... Full text Link to item Cite

Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy

Conference Lupus Science and Medicine · June 1, 2014 Objective: Epidemiological associations suggest vitamin D may play a role in inflammation and atherosclerosis. Using frozen serum and data from the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) trial, we assessed associations between ... Full text Cite